Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Dadar

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Neuroimage. Clinical|July 10, 2018
The relationship between brain atrophy and cognitive-behavioural symptoms in retired Canadian football players with multiple concussionsKaren Misquitta, Mahsa Dadar, Apameh Tarazi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 16, 2021
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementiaAna L Manera, Mahsa Dadar, John Cornelis Van Swieten, et al.
Brain : a Journal of Neurology|February 21, 2022
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementiaGolia Shafiei, Vincent Bazinet, Mahsa Dadar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 7, 2025
White matter hyperintensities precede other biomarkers in GRN frontotemporal dementiaMahdie Soltaninejad, Mahsa Dadar, D Louis Collins, et al.
IEEE Transactions on Medical Imaging|March 26, 2019
Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities and Results of the WMH Segmentation ChallengeHugo J Kuijf, J Matthijs Biesbroek, Jeroen De Bresser, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The PREVENT-AD cohort: accelerating Alzheimer's disease research and treatment in Canada and beyondSylvia Villeneuve, Judes Poirier, John C S Breitner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2025
The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyondSylvia Villeneuve, Judes Poirier, John C S Breitner, et al.
The Journal of Prevention of Alzheimer'S Disease|February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future researchEric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Neuroimage. Clinical|July 10, 2018
The relationship between brain atrophy and cognitive-behavioural symptoms in retired Canadian football players with multiple concussionsKaren Misquitta, Mahsa Dadar, Apameh Tarazi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 16, 2021
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementiaAna L Manera, Mahsa Dadar, John Cornelis Van Swieten, et al.
Brain : a Journal of Neurology|February 21, 2022
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementiaGolia Shafiei, Vincent Bazinet, Mahsa Dadar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 7, 2025
White matter hyperintensities precede other biomarkers in GRN frontotemporal dementiaMahdie Soltaninejad, Mahsa Dadar, D Louis Collins, et al.
IEEE Transactions on Medical Imaging|March 26, 2019
Standardized Assessment of Automatic Segmentation of White Matter Hyperintensities and Results of the WMH Segmentation ChallengeHugo J Kuijf, J Matthijs Biesbroek, Jeroen De Bresser, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The PREVENT-AD cohort: accelerating Alzheimer's disease research and treatment in Canada and beyondSylvia Villeneuve, Judes Poirier, John C S Breitner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2025
The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyondSylvia Villeneuve, Judes Poirier, John C S Breitner, et al.
The Journal of Prevention of Alzheimer'S Disease|February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future researchEric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Pageof 15